Serotonin 5-HT3 receptor antagonist for treatment of severe diabetic diarrhea.
作者信息
Murao Satoshi, Hosokawa Hitoshi
出版信息
Diabetes Care. 2010 Mar;33(3):e38. doi: 10.2337/dc09-2131.
Abstract
摘要
相似文献
1
Serotonin 5-HT3 receptor antagonist for treatment of severe diabetic diarrhea.用于治疗重度糖尿病性腹泻的5-羟色胺5-HT3受体拮抗剂。
Diabetes Care. 2010 Mar;33(3):e38. doi: 10.2337/dc09-2131.
2
Ramosetron might be useful for treating diabetic diarrhea with a rapid small bowel transit time.雷莫司琼可能对治疗伴有小肠转运时间加快的糖尿病性腹泻有用。
Korean J Intern Med. 2013 Jan;28(1):106-7. doi: 10.3904/kjim.2013.28.1.106. Epub 2012 Dec 28.
3
Effect of the 5-hydroxytryptamine3 (5-HT3)-receptor antagonist KB-R6933 on experimental diarrhea models.5-羟色胺3（5-HT3）受体拮抗剂KB-R6933对实验性腹泻模型的影响。
Jpn J Pharmacol. 1999 May;80(1):93-6. doi: 10.1254/jjp.80.93.
4
[Pharmacological and clinical profile of ramosetron hydrochloride (Irribow), a novel therapeutic agent for irritable bowel syndrome with diarrhea].[盐酸雷莫司琼（Irribow）——一种治疗腹泻型肠易激综合征的新型治疗药物的药理及临床概况]
Nihon Yakurigaku Zasshi. 2009 May;133(5):281-91. doi: 10.1254/fpj.133.281.
5
Inhibitory effects of ramosetron, a potent and selective 5-HT3-receptor antagonist, on conditioned fear stress-induced abnormal defecation and normal defecation in rats: comparative studies with antidiarrheal and spasmolytic agents.强效选择性5-羟色胺3（5-HT3）受体拮抗剂雷莫司琼对大鼠条件性恐惧应激诱导的异常排便和正常排便的抑制作用：与止泻药和解痉药的比较研究
J Pharmacol Sci. 2008 Feb;106(2):264-70. doi: 10.1254/jphs.fp0071943.
6
Pathophysiology, Differential Diagnosis, and Treatment of Diabetic Diarrhea.糖尿病性腹泻的病理生理学、鉴别诊断及治疗
Dig Dis Sci. 2019 Dec;64(12):3385-3393. doi: 10.1007/s10620-019-05846-6.
7
Serotonin and vasoactive intestinal peptide antagonists attenuate rotavirus diarrhoea.血清素和血管活性肠肽拮抗剂可减轻轮状病毒腹泻。
Gut. 2004 Jul;53(7):952-7. doi: 10.1136/gut.2003.033563.
8
9
5-HT3 receptor antagonists: new promising therapeutic agents in diabetes and its complications.
Acta Med Iran. 2013;51(10):736.
10
5-HT3 receptor antagonist for the treatment of tendinopathy.用于治疗肌腱病的5-羟色胺3受体拮抗剂。
Nat Clin Pract Rheumatol. 2008 Jul;4(7):E4.
引用本文的文献
1
A Comprehensive Review of Neuronal Changes in Diabetics.糖尿病患者神经元变化的综合综述
Cureus. 2021 Oct 30;13(10):e19142. doi: 10.7759/cureus.19142. eCollection 2021 Oct.
2
An update on the diagnosis and treatment of diabetic somatic and autonomic neuropathy.糖尿病躯体神经病变和自主神经病变的诊断与治疗进展
F1000Res. 2019 Feb 15;8. doi: 10.12688/f1000research.17118.1. eCollection 2019.
3
Diagnosing and managing diabetic somatic and autonomic neuropathy.糖尿病躯体神经病变和自主神经病变的诊断与管理
Ther Adv Endocrinol Metab. 2019 Feb 4;10:2042018819826890. doi: 10.1177/2042018819826890. eCollection 2019.
4
Diabetes Mellitus and the Colon.糖尿病与结肠
Curr Treat Options Gastroenterol. 2017 Dec;15(4):460-474. doi: 10.1007/s11938-017-0151-1.
5
Diabetes and the Small Intestine.糖尿病与小肠
Curr Treat Options Gastroenterol. 2017 Dec;15(4):490-507. doi: 10.1007/s11938-017-0155-x.
6
Is Ramosetron Really Useful to Treat Diabetic Diarrhea With Rapid Small Bowel Transit?: Author's Reply.雷莫司琼真的对治疗伴有小肠快速转运的糖尿病性腹泻有用吗？作者回复。
J Neurogastroenterol Motil. 2013 Apr;19(2):272. doi: 10.5056/jnm.2013.19.2.272.
7
Is ramosetron really useful to treat diabetic diarrhea with rapid small bowel transit?雷莫司琼真的对治疗伴有小肠快速转运的糖尿病性腹泻有效吗？
J Neurogastroenterol Motil. 2013 Apr;19(2):270-1. doi: 10.5056/jnm.2013.19.2.270.
8
Ramosetron might be useful for treating diabetic diarrhea with a rapid small bowel transit time.雷莫司琼可能对治疗伴有小肠转运时间加快的糖尿病性腹泻有用。
Korean J Intern Med. 2013 Jan;28(1):106-7. doi: 10.3904/kjim.2013.28.1.106. Epub 2012 Dec 28.
本文引用的文献
1
Diabetes and the enteric nervous system.糖尿病与肠神经系统。
Neurogastroenterol Motil. 2007 Dec;19(12):951-60. doi: 10.1111/j.1365-2982.2007.01023.x. Epub 2007 Oct 17.
2
The 5-HT3 receptor as a therapeutic target.5-羟色胺3受体作为一个治疗靶点。
Expert Opin Ther Targets. 2007 Apr;11(4):527-40. doi: 10.1517/14728222.11.4.527.
3
Fundamentals of neurogastroenterology.神经胃肠病学基础
Gut. 1999 Sep;45 Suppl 2(Suppl 2):II6-II16. doi: 10.1136/gut.45.2008.ii6.
4
Ondasentron in the treatment of diabetic diarrhea.昂丹司琼治疗糖尿病性腹泻。
Diabetes Care. 1994 May;17(5):453-4. doi: 10.2337/diacare.17.5.453b.
Zotero 插件